Federal contractor · BROOKLINE, MA

FEROMICS INC

No contract obligations recorded for FEROMICS INC in FY2026. Since FY2024: $4.1M. It also received $3.6M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
HUABW6E34U75
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 599.6KFY2024
  2. 3.5MFY2025

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for FEROMICS INC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

FEROMICS INC received $3.6M in federal assistance in FY2026, on 1 actions (1 new awards). Its largest program was 93.384 · Advanced Research Projects Agency for Health (Arpa-H) ($3.6M).

Assistance · FY2026
$3.6M
New awards
1
Actions
1

Assistance by fiscal year

  1. 3.6MFY2026

By type

  1. Direct payments$3.6M100%

Top programs

  1. 93.384 · Advanced Research Projects Agency for Health (Arpa-H)$3.6M100%

Awarding agencies

  1. National Institutes of Health$3.6M100%
    Department of Health and Human Services

Largest awards

  1. PLATFORM FOR RISK AND EFFICACY DETERMINATION USING IMMUNE CELL TRACKING IN ACUTE MYELOID LEUKEMIA (PREDICT-AML)$3.6M
    93.384 · Advanced Research Projects Agency for Health (Arpa-H)· National Institutes of Health· Direct payment for specified use· Sep 28, 2026 – Sep 28, 2026· AY2AX000239

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. CALYX SYSTEMS LLC$4.1M
    NEW YORK, NY · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. LYMPHATECH, INC$4.1M−100% in FY2026
    ATLANTA, GA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. CERAMEDIX HOLDING, LLC$4.2M+18% in FY2026
    NEW YORK, NY · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.